Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation

Journal of Child Neurology

Volumn 16, Issue 4, 2001, Pages 294-295

  Akar, Nejat ^a,b   Akar, Ece ^a   Yilmaz, Erkan ^a   Deda, Gülhis ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; GUANINE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENT; ADULT; ALLELE; ANALYSIS; ARTICLE; BRAIN INFARCTION; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; INFANT; METHODOLOGY; PRIORITY JOURNAL; RISK; STATISTICAL ANALYSIS; STROKE; THROMBOSIS; TURKEY (REPUBLIC);

EID: 0035011024     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380101600413     Document Type: Article

References (14)

1. Broderick J, Talbot T, Prenger E, et al: Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage. J Child Neurol 1993;8:250-255.
2. Riela AR, Roach ES: Etiology of stroke in children. J Child Neurol 1993;8:201-220.
3. Butler IJ: Cerebrovascular disorders of childhood. J Child Neurol 1993;8:197-200.
4. Akar N, Akar E, Deda G, et al: Factor V1691 G-A, prothrombin 20210 G-A and methylenetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999;14:749-751.
5. Wiman B, Hamsten A: Impaired fibrinolysis and risk of thromboembohsm. Prog Cardiovasc Dis 1991;34:179-192.
6. Stegnar M, Uhrin P, Peternel P, et al: The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 1998;79:975-979.
7. Junker R, Nabavi DG, Wolff E, et al: Plasminogen activator inhibitor-1 4G/5G genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost 1998;80:706-707.
8. Akar N, Yilmaz E, Akar E, et al: Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A. Thromb Res 2000;97:227-230.
9. Roest M, van der Schouw YT, Banga JD, et al: Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 2000;101:67-70.
10. Akar N, Akar E, Dalgin G, et al: Frequency of factor V 1691 G-A mutation in Turkish population. Thromb Haemost 1997;78:1527-1528.
11. Margaglione M, Grandone E, Capucci G, et al: An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997;77:605-606.
12. Gandrille S, Alhenc-Gelas M, Aiach M: A rapid screening method for the factor V Arg 506-Gln mutation. Blood Coagul Fibrinolysis 1995;6:245-248.
13. Rosendaal FR: Risk for venous thrombosis: Prevalence, risk and interaction. Semin Hematol 1997;34:171-187.
14. Kalafatis M, Mann KG: Factor V Leiden and thrombophilia. Arterioscler Thromb Vasc Biol 1997;17:620-627.